Kent A. Stevens, MD

Call
Website

Advertisement

Photos

1800 Orleans St
Baltimore, MD 21287
Dr. Stevens is an Associate Professor of Surgery at the Johns Hopkins School of Medicine and an attending surgeon at The Johns Hopkins Hospital. Dr. Stevens obtained his medical degree from the University of Arizona where he also completed his residency in general surgery. He subsequently completed a fellowship in Trauma/Surgical Critical Care at the University of Maryland, R. Adams Cowley Shock Trauma Center. During his fellowship, Dr. Stevens completed a Master of Public Health degree at the Johns Hopkins Bloomberg School of Public Health. Dr. Stevens’ research interests center on surgical and trauma-care strengthening in resource-poor settings. To support Dr. Stevens' research, visit: https://secure.jhu.edu/form/Stevens
Owner verified
See a problem?

You might also like

Pooja Yerramilli, MD

Pooja Yerramilli, MD

Dr. Anagnostou is an Associate Professor of Oncology, co-director of the Upper Aerodigestive Malignancies Program, director of the Thoracic Oncology Biorepository, leader of Precision Oncology Analytics and co-leader of the Molecular Tumor Board and the Thoracic Oncology Precision Medicine Center of Excellence in the Sidney Kimmel Cancer Center at Johns Hopkins. She has established the Molecular Oncology laboratory that seeks to understand the genomic wiring of response and resistance to immunotherapy through integrative genomic, transcriptomic, single-cell and liquid biopsy analyses of tumor and immune evolution. Dr. Anagnostou graduated from Medical School of the National and Kapodistrian University of Athens, Greece and received a PhD from the same institution. After completing her internal medicine residency at Yale-New Haven Hospital, she subsequently trained in Medical Oncology at Johns Hopkins. Dr. Anagnostou is a translational cancer investigator, focusing on large-scale genomic and liquid biopsy analyses in human cancers. Her group has discovered novel genomic mechanisms of response and resistance to immunotherapy and her research is particularly focused on understanding the molecular mechanisms of response and resistance to these therapies, capturing these by minimally invasive methods and translating this knowledge into novel technologies and innovative therapeutic approaches for cancer patients. She is the international study chair of the first ctDNA-based molecular response adaptive immuno-chemotherapy clinical trial for metastatic non-small cell lung cancer (NCT04093167). Dr. Anagnostou's long term goal is to transform medical oncology to personalized molecular oncology, where treatment decisions are tailored to cancer genomics and molecular real-time response assessments informed by liquid biopsies.
United StatesMarylandBaltimoreKent A. Stevens, MD

Yext

Advertisement